Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

J.Q. Tran, J. Rana, F. Barkhof, I. Melamed, H. Gevorkyan, M.P. Wattjes, R. Jong, K. Brosofsky, S. Ray, L. Xu, J. Zhao, E. Parr, D. Cadavid

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article numbere18
JournalNeurology neuroimmunology & neuroinflammation
Volume1
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

Tran, J.Q. ; Rana, J. ; Barkhof, F. ; Melamed, I. ; Gevorkyan, H. ; Wattjes, M.P. ; Jong, R. ; Brosofsky, K. ; Ray, S. ; Xu, L. ; Zhao, J. ; Parr, E. ; Cadavid, D. / Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. In: Neurology neuroimmunology & neuroinflammation. 2014 ; Vol. 1, No. 2.
@article{28986ef9bf5f4bb1a9296fe86837e217,
title = "Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033",
author = "J.Q. Tran and J. Rana and F. Barkhof and I. Melamed and H. Gevorkyan and M.P. Wattjes and R. Jong and K. Brosofsky and S. Ray and L. Xu and J. Zhao and E. Parr and D. Cadavid",
year = "2014",
doi = "10.1212/NXI.0000000000000018",
language = "Undefined/Unknown",
volume = "1",
journal = "Neurology neuroimmunology & neuroinflammation",
issn = "2332-7812",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Tran, JQ, Rana, J, Barkhof, F, Melamed, I, Gevorkyan, H, Wattjes, MP, Jong, R, Brosofsky, K, Ray, S, Xu, L, Zhao, J, Parr, E & Cadavid, D 2014, 'Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033' Neurology neuroimmunology & neuroinflammation, vol. 1, no. 2, e18. https://doi.org/10.1212/NXI.0000000000000018

Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. / Tran, J.Q.; Rana, J.; Barkhof, F.; Melamed, I.; Gevorkyan, H.; Wattjes, M.P.; Jong, R.; Brosofsky, K.; Ray, S.; Xu, L.; Zhao, J.; Parr, E.; Cadavid, D.

In: Neurology neuroimmunology & neuroinflammation, Vol. 1, No. 2, e18, 2014.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

AU - Tran, J.Q.

AU - Rana, J.

AU - Barkhof, F.

AU - Melamed, I.

AU - Gevorkyan, H.

AU - Wattjes, M.P.

AU - Jong, R.

AU - Brosofsky, K.

AU - Ray, S.

AU - Xu, L.

AU - Zhao, J.

AU - Parr, E.

AU - Cadavid, D.

PY - 2014

Y1 - 2014

U2 - 10.1212/NXI.0000000000000018

DO - 10.1212/NXI.0000000000000018

M3 - Article

VL - 1

JO - Neurology neuroimmunology & neuroinflammation

JF - Neurology neuroimmunology & neuroinflammation

SN - 2332-7812

IS - 2

M1 - e18

ER -